"Receptors, Androgen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA.
Descriptor ID |
D011944
|
MeSH Number(s) |
D12.776.826.750.150
|
Concept/Terms |
Receptors, Androgen- Receptors, Androgen
- Androgen Receptor
- Receptor, Androgen
- Androgen Receptors
- Dihydrotestosterone Receptors
- Testosterone Receptor
- Receptors, Androgens
- Androgens Receptors
- Receptors, Dihydrotestosterone
- Receptors, Stanolone
- Stanolone Receptors
- Stanolone Receptor
- Receptor, Stanolone
- 5 alpha-Dihydrotestosterone Receptor
- 5 alpha Dihydrotestosterone Receptor
- Receptor, 5 alpha-Dihydrotestosterone
- alpha-Dihydrotestosterone Receptor, 5
- Receptor, Testosterone
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Androgen".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Androgen".
This graph shows the total number of publications written about "Receptors, Androgen" by people in this website by year, and whether "Receptors, Androgen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 2 | 2 |
1995 | 2 | 3 | 5 |
1996 | 2 | 0 | 2 |
1997 | 0 | 1 | 1 |
1998 | 3 | 1 | 4 |
1999 | 6 | 4 | 10 |
2000 | 7 | 3 | 10 |
2001 | 3 | 4 | 7 |
2002 | 2 | 3 | 5 |
2003 | 13 | 4 | 17 |
2004 | 8 | 5 | 13 |
2005 | 12 | 8 | 20 |
2006 | 8 | 3 | 11 |
2007 | 6 | 9 | 15 |
2008 | 9 | 5 | 14 |
2009 | 13 | 6 | 19 |
2010 | 8 | 7 | 15 |
2011 | 11 | 8 | 19 |
2012 | 10 | 5 | 15 |
2013 | 12 | 10 | 22 |
2014 | 16 | 14 | 30 |
2015 | 10 | 5 | 15 |
2016 | 17 | 8 | 25 |
2017 | 12 | 7 | 19 |
2018 | 10 | 4 | 14 |
2019 | 10 | 4 | 14 |
2020 | 10 | 2 | 12 |
2021 | 10 | 5 | 15 |
2022 | 5 | 7 | 12 |
2023 | 3 | 7 | 10 |
2024 | 1 | 4 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Androgen" by people in Profiles.
-
Enzalutamide induces cytotoxicity in desmoplastic small round cell tumor independent of the androgen receptor. Commun Biol. 2024 Apr 04; 7(1):411.
-
The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide. Clin Cancer Res. 2024 Mar 15; 30(6):1152-1159.
-
Androgen drives melanoma invasiveness and metastatic spread by inducing tumorigenic fucosylation. Nat Commun. 2024 Feb 07; 15(1):1148.
-
Regulation of androgen receptor stability by the ?1 Pix/STUB1 complex. FASEB J. 2024 02; 38(2):e23408.
-
Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications. Cells. 2024 01 19; 13(2).
-
MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer. Cell Rep. 2023 10 31; 42(10):113221.
-
A GATA2-CDC6 axis modulates androgen receptor blockade-induced senescence in prostate cancer. J Exp Clin Cancer Res. 2023 Jul 29; 42(1):187.
-
The biology behind combining poly [ADP ribose] polymerase and androgen receptor inhibition for metastatic castration-resistant prostate cancer. Eur J Cancer. 2023 10; 192:113249.
-
The STAMPEDE2 Trial: a Site Survey of Current Patterns of Care, Access?to Imaging and Treatment of Metastatic Prostate Cancer. Clin Oncol (R Coll Radiol). 2023 10; 35(10):e628-e635.
-
Androgen-regulated stromal complement component 7 (C7) suppresses prostate cancer growth. Oncogene. 2023 08; 42(32):2428-2438.